Price Alert: Shares of CollPlant New (CLGN) Trade 5.15% Higher at Midday June 21

Equities Staff  |

CollPlant Biotechnologies Ltd New (NASDAQ: CLGN) has risen $0.43 (5.15%) and is currently sitting at $8.78, as of 11:04:39 est on June 21.

9,717 shares have exchanged hands.

The Company has increased 4.24% over the last 5 days and shares lost 16.08% over the last 30 days.

CollPlant New is set to release earnings on 2022-08-18.

For technical charts, analysis, and more on CollPlant New visit the company profile.

About CollPlant Biotechnologies Ltd New

CollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics. The Company's products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing, and are ushering in a new era in regenerative and aesthetic medicine. CollPlant recently entered a development and global commercialization agreement for dermal and soft tissue fillers with Allergan, an AbbVie company, the global leader in the dermal filler market.

To get more information on CollPlant Biotechnologies Ltd New and to follow the company's latest updates, you can visit the company's profile page here: CollPlant Biotechnologies Ltd New's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?



Market Movers

Sponsored Financial Content